Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. It operates through the Medical Equipment and Radiopharmaceuticals segments. It offers economical, end-to-end solutions for Positron Emission Tomography (PET) myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals, and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in Niagara Falls, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company